Direct-To-Consumer Advertising Analysis

837 Words2 Pages

Direct-to-consumer advertising for psychotropic medications is something that is so common place it is hard to believe that there was a time when we were not being told to ask our doctor about the newest antidepressant on the market. The Food and Drug Administration (FDA) lifted the ban on DTC advertisement for prescription medication in 1985 (Corrigan, Kosyluk, Konadu,& Park, 2014), but it was not until 1997 that it really took off. In 1997 the FDA made it so that companies could direct individuals to websites or toll-free numbers instead of giving Brief Summary that explained how the drug worked, the benefits, and the possible adverse effects (Lurie, 2009). As pharmaceutical companies pour billions of dollars into advertising every year, the question arises …show more content…

The marketing of psychotropic medications is a science unto itself that relies on push versus pull marketing (Becker, 2015). The push aspect comes from sales representatives going to prescribing doctors to market the drug while the pulls comes DTC advertisements urging consumers to ask their doctor about the medication (Becker, 2015). While there is evidence that listing the potential side effects will lowers the persuasiveness of an advertisement (Kavadas, Prevel Katsanis, & LeBel, 2007) this doesn’t seem to be the case since every dollar spent in advertisement has a return of over four dollars for the company (Becker, 2015). The Seroquel XR advertisement that was run in People Magazine was more than half warnings and possible side effects of the medication. It is hard to judge the effectiveness of this advertisement due to not having either major depressive disorder or bipolar disorder, but to have most of the ad proclaim the risks of the medication would create some concern about taking it. However, the tag line “Say ‘I’m OK’ and mean it!” is eye catching and can resonate with those who have mental illness

Open Document